Download PDF
CC BY 4.0 · TH Open 2019; 03(02): e132-e145
DOI: 10.1055/s-0039-1688934
Original Article
Georg Thieme Verlag KG Stuttgart · New York

The Ratio of Factor VIIa:Tissue Factor Content within Microvesicles Determines the Differential Influence on Endothelial Cells

Yahya Madkhali
1   Department of Biomedical Sciences, University of Hull, Hull, United Kingdom
2   Department of Medical Laboratories, College of Applied Medical Sciences, Majmaah University, KSA, Al Majmaah, Saudi Arabia
,
Sophie Featherby
1   Department of Biomedical Sciences, University of Hull, Hull, United Kingdom
,
Mary E. Collier
3   Department of Cardiovascular Sciences, University of Leicester, Glenfield General Hospital, Leicester, United Kingdom
,
Anthony Maraveyas
4   Division of Cancer–Hull York Medical School, University of Hull, Hull, United Kingdom
,
John Greenman
1   Department of Biomedical Sciences, University of Hull, Hull, United Kingdom
,
Camille Ettelaie 
1   Department of Biomedical Sciences, University of Hull, Hull, United Kingdom
› Author Affiliations
Further Information

Publication History

31 December 2018

10 April 2019

Publication Date:
15 May 2019 (online)

Also available at
   Permissions and Reprints

Abstract

Tissue factor (TF)-positive microvesicles from various sources can promote cellular proliferation or alternatively induce apoptosis, but the determining factors are unknown. In this study the hypothesis that the ratio of fVIIa:TF within microvesicles determines this outcome was examined. Microvesicles were isolated from HepG2, BxPC-3, 786-O, MDA-MB-231, and MCF-7 cell lines and microvesicle-associated fVIIa and TF antigen and activity levels were measured. Human coronary artery endothelial cells (HCAECs) were incubated with these purified microvesicles, or with combinations of fVIIa-recombinant TF, and cell proliferation/apoptosis was measured. Additionally, by expressing mCherry-PAR2 on HCAEC surface, PAR2 activation was quantified. Finally, the activation of PAR2 on HCAEC or the activities of TF and fVIIa in microvesicles were blocked prior to addition of microvesicles to cells. The purified microvesicles exhibited a range of fVIIa:TF ratios with HepG2 and 786-O cells having the highest (54:1) and lowest (10:1) ratios, respectively. The reversal from proapoptotic to proliferative was estimated to occur at a fVIIa:TF molar ratio of 15:1, but HCAEC could not be rescued at higher TF concentrations. The purified microvesicles induced HCAEC proliferation or apoptosis according to this ruling. Blocking PAR2 activation on HCAEC, or inhibiting fVIIa or TF-procoagulant function on microvesicles prevented the influence on HCAEC. Finally, incubation of HCAEC with recombinant TF resulted in increased surface exposure of fVII. The induction of cell proliferation or apoptosis by TF-positive microvesicles is dependent on the ratio of fVIIa:TF and involves the activation of PAR2. At lower TF concentrations, fVIIa can counteract the proapoptotic stimulus and induce proliferation.

Keywords

tissue factor - microvesicles - protease-activated receptor-2 - apoptosis - cell proliferation - factor VIIa

Authors' Contributions

The study was designed by Y.M., M.E.C., A.M., and C.E., and the experimental work was performed by Y.M., S.F., and C.E. The data were evaluated by Y.M., M.E.C., J.G., A.M., and C.E. and the manuscript was prepared by Y.M., J.G., and C.E.


Supplementary Material

 

  • References

  • 1 Kirchhofer D, Nemerson Y. Initiation of blood coagulation: the tissue factor/factor VIIa complex. Curr Opin Biotechnol 1996; 7 (04) 386-391
    CrossrefPubMedGoogle Scholar
  • 2 Edgington TS, Dickinson CD, Ruf W. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation. Thromb Haemost 1997; 78 (01) 401-405
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Morel O, Toti F, Hugel B. , et al. Procoagulant microparticles: disrupting the vascular homeostasis equation?. Arterioscler Thromb Vasc Biol 2006; 26 (12) 2594-2604
    CrossrefPubMedGoogle Scholar
  • 4 Freyssinet JM, Toti F. Formation of procoagulant microparticles and properties. Thromb Res 2010; 125 (Suppl. 01) S46-S48
    CrossrefPubMedGoogle Scholar
  • 5 Gardiner C, Harrison P, Belting M. , et al. Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day. J Extracell Vesicles 2015; 4: 26901
    CrossrefPubMedGoogle Scholar
  • 6 Date K, Hall J, Greenman J, Maraveyas A, Madden LA. Tumour and microparticle tissue factor expression and cancer thrombosis. Thromb Res 2013; 131 (02) 109-115
    CrossrefPubMedGoogle Scholar
  • 7 Hron G, Kollars M, Weber H. , et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 2007; 97 (01) 119-123
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Thaler J, Koder S, Kornek G, Pabinger I, Ay C. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation. Transl Res 2014; 163 (02) 145-150
    CrossrefPubMedGoogle Scholar
  • 9 Auwerda JJ, Yuana Y, Osanto S. , et al. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. Thromb Haemost 2011; 105 (01) 14-20
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Kask L, Jorsback A, Winkvist M. , et al. Identification of novel downstream molecules of tissue factor activation by comparative proteomic analysis. J Proteome Res 2014; 13 (02) 477-488
    CrossrefPubMedGoogle Scholar
  • 11 Ramchandani D, Unruh D, Lewis CS, Bogdanov VY, Weber GF. Activation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditions. Lab Invest 2016; 96 (12) 1234-1245
    PubMedGoogle Scholar
  • 12 Zelaya H, Rothmeier AS, Ruf W. Tissue factor at the crossroad of coagulation and cell signaling. J Thromb Haemost 2018; 16 (10) 1941-1952
    CrossrefPubMedGoogle Scholar
  • 13 McVey JH. The role of the tissue factor pathway in haemostasis and beyond. Curr Opin Hematol 2016; 23 (05) 453-461
    CrossrefPubMedGoogle Scholar
  • 14 Rothmeier AS, Liu E, Chakrabarty S. , et al. Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling. Blood 2018; 131 (06) 674-685
    CrossrefPubMedGoogle Scholar
  • 15 Fan L, Yotov WV, Zhu T. , et al. Tissue factor enhances protease-activated receptor-2-mediated factor VIIa cell proliferative properties. J Thromb Haemost 2005; 3 (05) 1056-1063
    CrossrefPubMedGoogle Scholar
  • 16 Cirillo P, Calì G, Golino P. , et al. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation 2004; 109 (23) 2911-2916
    CrossrefPubMedGoogle Scholar
  • 17 Wu B, Zhou H, Hu L, Mu Y, Wu Y. Involvement of PKCα activation in TF/VIIa/PAR2-induced proliferation, migration, and survival of colon cancer cell SW620. Tumour Biol 2013; 34 (02) 837-846
    CrossrefPubMedGoogle Scholar
  • 18 Gessler F, Voss V, Dützmann S, Seifert V, Gerlach R, Kögel D. Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells. Neuroscience 2010; 165 (04) 1312-1322
    CrossrefPubMedGoogle Scholar
  • 19 Versteeg HH, Ruf W. Emerging insights in tissue factor-dependent signaling events. Semin Thromb Hemost 2006; 32 (01) 24-32
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Kocatürk B, Van den Berg YW, Tieken C. , et al. Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner. Proc Natl Acad Sci U S A 2013; 110 (28) 11517-11522
    CrossrefPubMedGoogle Scholar
  • 21 Collier ME, Ettelaie C. Induction of endothelial cell proliferation by recombinant and microparticle-tissue factor involves beta1-integrin and extracellular signal regulated kinase activation. Arterioscler Thromb Vasc Biol 2010; 30 (09) 1810-1817
    CrossrefPubMedGoogle Scholar
  • 22 Rak J, Milsom C, Yu J. Tissue factor in cancer. Curr Opin Hematol 2008; 15 (05) 522-528
    CrossrefPubMedGoogle Scholar
  • 23 Schaffner F, Ruf W. Tissue factor and PAR2 signaling in the tumor microenvironment. Arterioscler Thromb Vasc Biol 2009; 29 (12) 1999-2004
    CrossrefPubMedGoogle Scholar
  • 24 Lee BJ, Kim JH, Woo SH, Kim JH, Kim DH, Yu YS. Tissue factor is involved in retinoblastoma cell proliferation via both the Akt and extracellular signal-regulated kinase pathways. Oncol Rep 2011; 26 (03) 665-670
    PubMedGoogle Scholar
  • 25 Pradier A, Ettelaie C. The influence of exogenous tissue factor on the regulators of proliferation and apoptosis in endothelial cells. J Vasc Res 2008; 45 (01) 19-32
    CrossrefPubMedGoogle Scholar
  • 26 Alkistis Frentzou G, Collier ME, Seymour AM, Ettelaie C. Differential induction of cellular proliferation, hypertrophy and apoptosis in H9c2 cardiomyocytes by exogenous tissue factor. Mol Cell Biochem 2010; 345 (1–2): 119-130
    CrossrefPubMedGoogle Scholar
  • 27 ElKeeb AM, Collier ME, Maraveyas A, Ettelaie C. Accumulation of tissue factor in endothelial cells induces cell apoptosis, mediated through p38 and p53 activation. Thromb Haemost 2015; 114 (02) 364-378
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Aharon A, Tamari T, Brenner B. Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells. Thromb Haemost 2008; 100 (05) 878-885
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Shinagawa K, Ploplis VA, Castellino FJ. A severe deficiency of coagulation factor VIIa results in attenuation of the asthmatic response in mice. Am J Physiol Lung Cell Mol Physiol 2009; 296 (05) L763-L770
    CrossrefPubMedGoogle Scholar
  • 30 Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 2000; 97 (10) 5255-5260
    CrossrefPubMedGoogle Scholar
  • 31 Riewald M, Ruf W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci U S A 2001; 98 (14) 7742-7747
    CrossrefPubMedGoogle Scholar
  • 32 Schaffner F, Ruf W. Tissue factor and protease-activated receptor signaling in cancer. Semin Thromb Hemost 2008; 34 (02) 147-153
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Hjortoe GM, Petersen LC, Albrektsen T. , et al. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 2004; 103 (08) 3029-3037
    CrossrefPubMedGoogle Scholar
  • 34 Boulanger CM, Scoazec A, Ebrahimian T. , et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104 (22) 2649-2652
    CrossrefPubMedGoogle Scholar
  • 35 Morel O, Toti F, Hugel B, Freyssinet JM. Cellular microparticles: a disseminated storage pool of bioactive vascular effectors. Curr Opin Hematol 2004; 11 (03) 156-164
    CrossrefPubMedGoogle Scholar
  • 36 Morel O, Toti F, Bakouboula B, Grunebaum L, Freyssinet JM. Procoagulant microparticles: ‘criminal partners’ in atherothrombosis and deleterious cellular exchanges. Pathophysiol Haemost Thromb 2006; 35 (1–2): 15-22
    CrossrefPubMedGoogle Scholar
  • 37 Morel O, Morel N, Freyssinet JM, Toti F. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses. Platelets 2008; 19 (01) 9-23
    CrossrefPubMedGoogle Scholar
  • 38 Collier ME, Mah PM, Xiao Y, Maraveyas A, Ettelaie C. Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity. Thromb Haemost 2013; 110 (05) 966-976
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Yang Q, Underwood MJ, Hsin MK, Liu XC, He GW. Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development. Curr Drug Metab 2008; 9 (07) 661-667
    CrossrefPubMedGoogle Scholar
  • 40 Kuge Y, Kume N, Ishino S. , et al. Prominent lectin-like oxidized low density lipoprotein (LDL) receptor-1 (LOX-1) expression in atherosclerotic lesions is associated with tissue factor expression and apoptosis in hypercholesterolemic rabbits. Biol Pharm Bull 2008; 31 (08) 1475-1482
    CrossrefPubMedGoogle Scholar
  • 41 Ettelaie C, Collier MEW, Maraveyas A, Ettelaie R. Characterization of physical properties of tissue factor-containing microvesicles and a comparison of ultracentrifuge-based recovery procedures. J Extracell Vesicles 2014; 3: 10
    PubMedGoogle Scholar
  • 42 Ettelaie C, Collier MEW, Featherby S, Greenman J, Maraveyas A. Peptidyl-prolyl isomerase 1 (Pin1) preserves the phosphorylation state of tissue factor and prolongs its release within microvesicles. Biochim Biophys Acta Mol Cell Res 2018; 1865 (01) 12-24
    CrossrefPubMedGoogle Scholar
  • 43 Benelhaj NE, Maraveyas A, Featherby S, Collier MEW, Johnson MJ, Ettelaie C. Alteration in endothelial permeability occurs in response to the activation of PAR2 by factor Xa but not directly by the TF-factor VIIa complex. Thromb Res 2019; 175: 13-20
    CrossrefPubMedGoogle Scholar
  • 44 Collier MEW, Ettelaie C, Goult BT, Maraveyas A, Goodall AH. Investigation of the filamin A-dependent mechanisms of tissue factor incorporation into microvesicles. Thromb Haemost 2017; 117 (11) 2034-2044
    Article in Thieme ConnectPubMedGoogle Scholar
  • 45 Ettelaie C, Collier ME, Featherby S, Benelhaj NE, Greenman J, Maraveyas A. Analysis of the potential of cancer cell lines to release tissue factor-containing microvesicles: correlation with tissue factor and PAR2 expression. Thromb J 2016; 14: 2
    CrossrefPubMedGoogle Scholar
  • 46 Broze Jr GJ, Hickman S, Miletich JP. Monoclonal anti-human factor VII antibodies. Detection in plasma of a second protein antigenically and genetically related to factor VII. J Clin Invest 1985; 76 (03) 937-946
    CrossrefPubMedGoogle Scholar
  • 47 Böhm E, Seyfried BK, Dockal M. , et al. Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells. BMC Biotechnol 2015; 15: 87
    CrossrefPubMedGoogle Scholar
  • 48 Buendía P, Montes de Oca A, Madueño JA. , et al. Endothelial microparticles mediate inflammation-induced vascular calcification. FASEB J 2015; 29 (01) 173-181
    CrossrefPubMedGoogle Scholar
  • 49 Harter PN, Dützmann S, Drott U. , et al. Anti-tissue factor (TF9-10H10) treatment reduces tumor cell invasiveness in a novel migratory glioma model. Neuropathology 2013; 33 (05) 515-525
    PubMedGoogle Scholar
  • 50 Versteeg HH, Schaffner F, Kerver M. , et al. Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008; 111 (01) 190-199
    CrossrefPubMedGoogle Scholar
  • 51 Teplyakov A, Obmolova G, Malia TJ. , et al. Crystal structure of tissue factor in complex with antibody 10H10 reveals the signaling epitope. Cell Signal 2017; 36: 139-144
    CrossrefPubMedGoogle Scholar
  • 52 Basavaraj MG, Olsen JO, Østerud B, Hansen JB. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. Thromb Res 2012; 130 (03) 538-546
    CrossrefPubMedGoogle Scholar
  • 53 Liu R, Tan YZ, Wang HJ, Zhang M. Sorting of lymphatic endothelial progenitor cells from canine peripheral blood and their differentiation induction towards endothelial cells [in Chinese]. Zhonghua Xue Ye Xue Za Zhi 2007; 28 (03) 169-173
    PubMedGoogle Scholar